These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
351 related articles for article (PubMed ID: 10908627)
1. Rescue of locomotor impairment in dopamine D2 receptor-deficient mice by an adenosine A2A receptor antagonist. Aoyama S; Kase H; Borrelli E J Neurosci; 2000 Aug; 20(15):5848-52. PubMed ID: 10908627 [TBL] [Abstract][Full Text] [Related]
2. Antipsychotic-Like Efficacy of Dopamine D Sahlholm K; Gómez-Soler M; Valle-León M; López-Cano M; Taura JJ; Ciruela F; Fernández-Dueñas V Mol Neurobiol; 2018 Jun; 55(6):4952-4958. PubMed ID: 28779351 [TBL] [Abstract][Full Text] [Related]
3. Allosteric Interactions between Adenosine A Prasad K; de Vries EFJ; Elsinga PH; Dierckx RAJO; van Waarde A Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572077 [TBL] [Abstract][Full Text] [Related]
4. Adenosine A2A agonist CGS 21680 decreases the affinity of dopamine D2 receptors for dopamine in human striatum. Díaz-Cabiale Z; Hurd Y; Guidolin D; Finnman UB; Zoli M; Agnati LF; Vanderhaeghen JJ; Fuxe K; Ferré S Neuroreport; 2001 Jul; 12(9):1831-4. PubMed ID: 11435907 [TBL] [Abstract][Full Text] [Related]
5. The role of the D(2) dopamine receptor (D(2)R) in A(2A) adenosine receptor (A(2A)R)-mediated behavioral and cellular responses as revealed by A(2A) and D(2) receptor knockout mice. Chen JF; Moratalla R; Impagnatiello F; Grandy DK; Cuellar B; Rubinstein M; Beilstein MA; Hackett E; Fink JS; Low MJ; Ongini E; Schwarzschild MA Proc Natl Acad Sci U S A; 2001 Feb; 98(4):1970-5. PubMed ID: 11172060 [TBL] [Abstract][Full Text] [Related]
6. The mGlu Romero-Fernandez W; Taura JJ; Crans RAJ; Lopez-Cano M; Fores-Pons R; Narváez M; Carlsson J; Ciruela F; Fuxe K; Borroto-Escuela DO Mol Neurobiol; 2022 Oct; 59(10):5955-5969. PubMed ID: 35829830 [TBL] [Abstract][Full Text] [Related]
7. Boolean analysis shows a high proportion of dopamine D Rivas-Santisteban R; Rico AJ; Muñoz A; Rodríguez-Pérez AI; Reyes-Resina I; Navarro G; Labandeira-García JL; Lanciego JL; Franco R Neurobiol Dis; 2023 Nov; 188():106341. PubMed ID: 37918757 [TBL] [Abstract][Full Text] [Related]
8. Adenosine A2A receptors modify motor function in MPTP-treated common marmosets. Kanda T; Tashiro T; Kuwana Y; Jenner P Neuroreport; 1998 Aug; 9(12):2857-60. PubMed ID: 9760134 [TBL] [Abstract][Full Text] [Related]
9. Progress in pursuit of therapeutic A2A antagonists: the adenosine A2A receptor selective antagonist KW6002: research and development toward a novel nondopaminergic therapy for Parkinson's disease. Kase H; Aoyama S; Ichimura M; Ikeda K; Ishii A; Kanda T; Koga K; Koike N; Kurokawa M; Kuwana Y; Mori A; Nakamura J; Nonaka H; Ochi M; Saki M; Shimada J; Shindou T; Shiozaki S; Suzuki F; Takeda M; Yanagawa K; Richardson PJ; Jenner P; Bedard P; Borrelli E; Hauser RA; Chase TN; Neurology; 2003 Dec; 61(11 Suppl 6):S97-100. PubMed ID: 14663020 [TBL] [Abstract][Full Text] [Related]
10. Metabotropic glutamate mGlu5 receptor-mediated modulation of the ventral striopallidal GABA pathway in rats. Interactions with adenosine A(2A) and dopamine D(2) receptors. Díaz-Cabiale Z; Vivó M; Del Arco A; O'Connor WT; Harte MK; Müller CE; Martínez E; Popoli P; Fuxe K; Ferré S Neurosci Lett; 2002 May; 324(2):154-8. PubMed ID: 11988350 [TBL] [Abstract][Full Text] [Related]
12. Altered adenosine 2A and dopamine D2 receptor availability in the 6-hydroxydopamine-treated rats with and without levodopa-induced dyskinesia. Zhou X; Doorduin J; Elsinga PH; Dierckx RAJO; de Vries EFJ; Casteels C Neuroimage; 2017 Aug; 157():209-218. PubMed ID: 28583881 [TBL] [Abstract][Full Text] [Related]
13. Allosteric interactions between agonists and antagonists within the adenosine A2A receptor-dopamine D2 receptor heterotetramer. Bonaventura J; Navarro G; Casadó-Anguera V; Azdad K; Rea W; Moreno E; Brugarolas M; Mallol J; Canela EI; Lluís C; Cortés A; Volkow ND; Schiffmann SN; Ferré S; Casadó V Proc Natl Acad Sci U S A; 2015 Jul; 112(27):E3609-18. PubMed ID: 26100888 [TBL] [Abstract][Full Text] [Related]
14. Essential Control of the Function of the Striatopallidal Neuron by Pre-coupled Complexes of Adenosine A Ferré S; Bonaventura J; Zhu W; Hatcher-Solis C; Taura J; Quiroz C; Cai NS; Moreno E; Casadó-Anguera V; Kravitz AV; Thompson KR; Tomasi DG; Navarro G; Cordomí A; Pardo L; Lluís C; Dessauer CW; Volkow ND; Casadó V; Ciruela F; Logothetis DE; Zwilling D Front Pharmacol; 2018; 9():243. PubMed ID: 29686613 [TBL] [Abstract][Full Text] [Related]
15. Decreased striatal adenosine A Valle-León M; Callado LF; Aso E; Cajiao-Manrique MM; Sahlholm K; López-Cano M; Soler C; Altafaj X; Watanabe M; Ferré S; Fernández-Dueñas V; Menchón JM; Ciruela F Neuropsychopharmacology; 2021 Feb; 46(3):665-672. PubMed ID: 33010795 [TBL] [Abstract][Full Text] [Related]
16. Acute cocaine treatment enhances the antagonistic allosteric adenosine A2A-dopamine D2 receptor-receptor interactions in rat dorsal striatum without increasing significantly extracellular dopamine levels. Romero-Fernandez W; Zhou Z; Beggiato S; Wydra K; Filip M; Tanganelli S; Borroto-Escuela DO; Ferraro L; Fuxe K Pharmacol Rep; 2020 Apr; 72(2):332-339. PubMed ID: 32124388 [TBL] [Abstract][Full Text] [Related]
17. cAMP-producing chemogenetic and adenosine A2a receptor activation inhibits the inwardly rectifying potassium current in striatal projection neurons. Wang Q; Zhou FM Neuropharmacology; 2019 Apr; 148():229-243. PubMed ID: 30659840 [TBL] [Abstract][Full Text] [Related]
18. Effects of Long-Term Alcohol Drinking on the Dopamine D2 Receptor: Gene Expression and Heteroreceptor Complexes in the Striatum in Rats. Feltmann K; Borroto-Escuela DO; Rüegg J; Pinton L; de Oliveira Sergio T; Narváez M; Jimenez-Beristain A; Ekström TJ; Fuxe K; Steensland P Alcohol Clin Exp Res; 2018 Feb; 42(2):338-351. PubMed ID: 29205397 [TBL] [Abstract][Full Text] [Related]
19. Caffeine plus haloperidol reduces fatigue in an experimental model of Parkinson's disease - a prospective to A de Bem Alves AC; Aguiar AS Purinergic Signal; 2024 Feb; 20(1):29-34. PubMed ID: 36918462 [TBL] [Abstract][Full Text] [Related]
20. Neuroprotection by caffeine in the MPTP model of parkinson's disease and its dependence on adenosine A2A receptors. Xu K; Di Luca DG; Orrú M; Xu Y; Chen JF; Schwarzschild MA Neuroscience; 2016 May; 322():129-37. PubMed ID: 26905951 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]